ResMed Cash End of Year vs Share Based Compensation Analysis

RMD -- USA Stock  

USD 106.28  0.48  0.45%

ResMed financial indicator trend analysis is much more than just breaking down ResMed prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether ResMed is a good investment. Please check the relationship between ResMed Cash End of Year and its Share Based Compensation accounts. Additionally take a look at Your Equity Center.

Cash End of Year vs Share Based Compensation

Accounts Relationship

Cash End of Year vs Share Based Compensation

Significance: Fragmental Relationship

Overlapping area represents amount of trend that can be explained by analyzing historical patterns of ResMed Cash End of Year account and Share Based Compensation

Correlation Coefficient

0.54
Relationship DirectionPositive 
Relationship StrengthWeak

Cash End of Year

Share Based Compensation

A component of Net Cash Flow from Operations representing the total amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.

Did you try this?

Run Portfolio Volatility Now
   

Portfolio Volatility

Check portfolio volatility and analyze historical return density to properly model market risk
All  Next Launch Portfolio Volatility

Generate Optimal Portfolios

Align your risk and return expectations
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Additionally take a look at Your Equity Center. Please also try Fundamental Analysis module to view fundamental data based on most recent published financial statements.